J. Kimata

发表

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

P. Hotez, J. Pollet, A. Bailey, 2021, bioRxiv.

Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate

P. Hotez, J. Pollet, A. Bailey, 2021, Protein Expression and Purification.

Stepping toward a Macaque Model of HIV-1 Induced AIDS

J. Kimata, 2014, Viruses.

Potent and Broad Anti-HIV-1 Activity Exhibited by a Glycosyl-Phosphatidylinositol-Anchored Peptide Derived from the CDR H3 of Broadly Neutralizing Antibody PG16

Y. Shao, P. Zhou, Mengran Qian, 2011, Journal of Virology.

Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor

P. Zhou, Qianqian Zhu, J. Kimata, 2016, Journal of Neuroimmune Pharmacology.

Immunogenicity and protective efficacy of Gag/Pol/Env vaccines derived from temporal isolates of SIVmne against cognate virus challenge

J. Overbaugh, Shiu-Lok Hu, J. Kimata, 2007, Journal of medical primatology.

IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells.

D. Rowley, Megan B Vogt, R. Rico-Hesse, 2020, PloS one.

Vpx is Critical for SIVmne infection of pigtail macaques

L. Ratner, Charles R. Brown, V. Hirsch, 2012, Retrovirology.

Plasma Levels of Complement Factor I and C4b Peptides Are Associated with HIV Suppression

Christopher J. Lyon, Xu G. Yu, Zhengyu Ouyang, 2017, ACS infectious diseases.

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

P. Hotez, J. Pollet, M. Bottazzi, 2021, Human vaccines & immunotherapeutics.

Absence of XMRV in Peripheral Blood Mononuclear Cells of ARV-Treatment Naïve HIV-1 Infected and HIV-1/HCV Coinfected Individuals and Blood Donors

R. Arduino, J. Kimata, K. Vigil, 2012, PloS one.

A decrease in albumin in early SIV infection is related to viral pathogenicity.

J. Overbaugh, M. Wener, S. Holte, 2009, AIDS research and human retroviruses.

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern

P. Hotez, J. Pollet, Zhuyun Liu, 2022, Vaccine.

Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid.

J. Gordon, L. Ratner, R. Heuckeroth, 1989, Proceedings of the National Academy of Sciences of the United States of America.

ICAM-3 influences human immunodeficiency virus type 1 replication in CD4(+) T cells independent of DC-SIGN-mediated transmission.

R. Arora, J. Kimata, J. Biggins, 2007, Virology.

Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I.

T. Ley, L. Ratner, W. Grossman, 1995, Proceedings of the National Academy of Sciences of the United States of America.

HIV replication in conjunction with granzyme B production by CCR5+ memory CD4 T cells: Implications for bystander cell and tissue pathologies.

T. Savidge, P. Urvil, M. Medina, 2014, Virology.

Coreceptor Specificity of Temporal Variants of Simian Immunodeficiency Virus Mne

J. Overbaugh, D. Littman, V. KewalRamani, 1999, Journal of Virology.

HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H.

A. Mangano, R. Bologna, J. Kimata, 2022, The Journal of antimicrobial chemotherapy.

In vivo serial passaging of human-simian immunodeficiency virus clones identifies viral characteristics that enhance persistent viral replication

Shiu-Lok Hu, D. Kaushal, S. Chandrasekar, 2021, bioRxiv.

The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1

Zhiwei Chen, S. Benichou, P. Zhou, 2016, Journal of Virology.

Changes in the Extracellular Envelope Glycoprotein of Variants That Evolve during the Course of Simian Immunodeficiency Virus SIVMne Infection Affect Neutralizing Antibody Recognition, Syncytium Formation, and Macrophage Tropism but Not Replication, Cytopathicity, or CCR-5 Coreceptor Recognition

J. Overbaugh, B. Chackerian, J. Kimata, 1998, Journal of Virology.

Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates

Jean A. Niles, M. Ferrari, S. Demaria, 2020, Advanced therapeutics.

Preventive efficacy of a tenofovir alafenamide fumarate nanofluidic implant in SHIV-challenged nonhuman primates

Jean A. Niles, M. Ferrari, S. Demaria, 2020, bioRxiv.

Functional and Antigenic Characterization of Human, Rhesus Macaque, Pigtailed Macaque, and Murine DC-SIGN

R. Doms, J. Hoxie, D. Littman, 2001, Journal of Virology.

SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses

A. Rice, J. Kimata, 2021, Future virology.

Viral load Reduction in SHIV-Positive Nonhuman Primates via Long-Acting Subcutaneous Tenofovir Alafenamide Fumarate Release from a Nanofluidic Implant

S. Demaria, A. Grattoni, M. Marzinke, 2020, Pharmaceutics.

The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway

L. Ratner, T. Palker, J. Kimata, 1993, Journal of virology.

Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization

L. Ratner, J. Kimata, 1991, Journal of virology.

Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations

A. Somasunderam, B. Smulevitz, R. Arduino, 2020 .

Timing of antiretroviral therapy initiation determines rectal NK cell populations.

A. Somasunderam, B. Smulevitz, R. Arduino, 2019, AIDS research and human retroviruses.

Dendritic Cell–Mediated HIV-1 Infection of T Cells Demonstrates a Direct Relationship to Plasma Viral RNA Levels

R. Arora, R. Arduino, J. Kimata, 2010, Journal of acquired immune deficiency syndromes.

A seroepidemiologic survey of human T-cell lymphotropic virus type I in two Hawaiian hematologic-oncologic practices.

J. Kimata, M. Kaneshiro, J. Nakamura, 1989, The Western journal of medicine.

PG16 Is a Potent HIV-1 Entry Inhibitor HCDR3 of Broadly Neutralizing Antibody Glycosylphosphatidylinositol-Anchored Trimeric

P. Zhou, Lifei Yang, J. Kimata, 2013 .

Trimeric Glycosylphosphatidylinositol-Anchored HCDR3 of Broadly Neutralizing Antibody PG16 Is a Potent HIV-1 Entry Inhibitor

P. Zhou, Lifei Yang, J. Kimata, 2012, Journal of Virology.

Ultra-long-acting refillable nanofluidic implant confers full protection against SHIV infection in non-human primates

M. Ittmann, A. Grattoni, J. Campa-Carranza, 2022, bioRxiv.

Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern

P. Hotez, J. Pollet, M. Bottazzi, 2021, bioRxiv.

Toward a Macaque Model of HIV-1 Infection: Roadblocks, Progress, and Future Strategies

D. Kaushal, J. Kimata, Rajesh Thippeshappa, 2020, Frontiers in Microbiology.

CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection

Di Zhang, P. Zhou, J. Kimata, 2014, PloS one.

Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives

J. Kimata, Hongmei Ruan, Rajesh Thippeshappa, 2012, Biology.

GPI-anchored single chain Fv - an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike

R. Arora, P. Zhou, J. Kimata, 2010, Retrovirology.

Serum IgG anti-SARS-CoV-2 Binding Antibody Level Is Strongly Associated With IgA and Functional Antibody Levels in Adults Infected With SARS-CoV-2

A. Rice, L. S. Angelo, P. Piedra, 2021, Frontiers in Immunology.

A Rapid, High Throughput, Viral Infectivity Assay using Automated Brightfield Microscopy with Machine Learning

I. Goldberg, I. Jordan, A.Romero Frías, 2022, bioRxiv.

Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones.

L. Ratner, F. Wong, J. Kimata, 1994, Virology.

HIV-1 Transmission, Replication Fitness and Disease Progression

J. Kimata, Tasha Biesinger, 2008, Virology : research and treatment.

The Viral Restriction Factor Tetherin Prevents Leucine-rich Pentatricopeptide Repeat-containing Protein (LRPPRC) from Association with Beclin 1 and B-cell CLL/lymphoma 2 (Bcl-2) and Enhances Autophagy and Mitophagy*

Leyuan Liu, F. Yue, J. Kimata, 2015, The Journal of Biological Chemistry.

Full-coverage native RNA sequencing of HIV-1 viruses

J. Kimata, A. Gener, 2019, bioRxiv.

Subversion of Cell Cycle Regulatory Mechanisms by HIV.

A. Rice, J. Kimata, A. P. Rice, 2015, Cell host & microbe.

Macaques as model hosts for studies of HIV-1 infection

J. Kimata, Rajesh Thippeshappa, Anisha Misra, 2013, Front. Microbiol..

Highly Pathogenic Simian Immunodeficiency Virus mne Variants That Emerge during the Course of Infection Evolve Enhanced Infectivity and the Ability To Downregulate CD4 but Not Class I Major Histocompatibility Complex Antigens

J. Kimata, J. Biggins, Monica T Yu Kimata, 2002, Journal of Virology.

A Variant Macaque-Tropic Human Immunodeficiency Virus Type 1 Is Resistant to Alpha Interferon-Induced Restriction in Pig-Tailed Macaque CD4+ T Cells

P. Zhou, J. Kimata, Weiming Wang, 2013, Journal of Virology.

Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression

D. B. Anderson, J. Overbaugh, L. Kuller, 1999, Nature Medicine.

PACS1 is an HIV-1 cofactor that functions in Rev-mediated nuclear export of viral RNA.

A. Rice, R. Lloyd, D. Lewis, 2019, Virology.

Challenges and strategies for the eradication of the HIV reservoir.

A. Rice, Jin Wang, J. Kimata, 2016, Current opinion in immunology.

Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector.

C. Qin, P. Zhou, Z. Cong, 2017, Human gene therapy.

Vif Substitution Enables Persistent Infection of Pig-Tailed Macaques by Human Immunodeficiency Virus Type 1

R. Arora, Shiu-Lok Hu, P. Zhou, 2011, Journal of Virology.

In vivo Serial Passaging of Human–Simian Immunodeficiency Virus Clones Identifies Characteristics for Persistent Viral Replication

Shiu-Lok Hu, D. Kaushal, S. Chandrasekar, 2021, Frontiers in Microbiology.

A. Chakraborty, S. Sur, J. Kimata, 2020, Journal of Allergy and Clinical Immunology.

The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env

J. Overbaugh, J. Kimata, 1997, Journal of virology.

Changes in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4+ T cells.

J. Kimata, Tasha Biesinger, Monica T Yu Kimata, 2008, Virology.

A Lymph Node-Derived Cytopathic Simian Immunodeficiency Virus Mne Variant Replicates in Nonstimulated Peripheral Blood Mononuclear Cells

J. Overbaugh, Afsaneh Mozaffarian, J. Kimata, 1998, Journal of Virology.

Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation

J. Allan, J. Kimata, B. Wilson, 2010, Retrovirology.

Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection

Jerome H. Kim, N. Frahm, M. Robb, 2018, PLoS pathogens.

Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity

P. Zhou, J. Kimata, Weiming Wang, 2018, Journal of Virology.

HIV-1 fitness and disease progression: insights from the SIV-macaque model.

J. Kimata, 2006, Current HIV research.

The increased replicative capacity of a late-stage simian immunodeficiency virus mne variant is evident in macrophage- or dendritic cell-T-cell cocultures.

J. Kimata, Joelle M. Wilson, Parul G. Patel, 2004, Virology.

Capture and Transfer of Simian Immunodeficiency Virus by Macaque Dendritic Cells Is Enhanced by DC-SIGN

M. Colonna, M. Cella, J. Allan, 2002, Journal of Virology.

Identification of a Simian Immunodeficiency Virus Reverse Transcriptase Variant with Enhanced Replicational Fidelity in the Late Stage of Viral Infection*

Tracy L. Diamond, J. Kimata, Baek Kim, 2001, The Journal of Biological Chemistry.

Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population.

J. Overbaugh, R. Benveniste, J. Kimata, 1995, Virology.

Heavily glycosylated, highly fit SIVMne variants continue to diversify and undergo selection after transmission to a new host and they elicit early antibody dependent cellular responses but delayed neutralizing antibody responses

J. Overbaugh, Xueling Wu, G. Landucci, 2008, Virology Journal.

Clearance of HIV infection by selective elimination of host cells capable of producing HIV

E. Graviss, Min Chen, Jin Wang, 2020, Nature Communications.

Suppression of Viremia and Evolution of Human Immunodeficiency Virus Type 1 Drug Resistance in a Macaque Model for Antiretroviral Therapy

J. Lifson, J. Mellors, J. Coffin, 2007, Journal of Virology.

Integration of Human Immunodeficiency Virus Type 1 in Untreated Infection Occurs Preferentially within Genes

R. Arora, A. Rice, R. Arduino, 2006, Journal of Virology.

Cellular cofactors and HIV-1 infection in vivo

A. Rice, J. Kimata, A. P. Rice, 2006 .

CD3-dependent lymphocyte activation by human T cell leukaemia virus type I-producing T cells.

L. Ratner, F. Wong, J. Kimata, 1994, The Journal of general virology.

Efficient pre-catalytic conformational change of reverse transcriptases from SAMHD1 non-counteracting primate lentiviruses during dNTP incorporation.

R. Schinazi, Baek Kim, Dong-Hyun Kim, 2019, Virology.

Clearance of HIV‐1 or SIV reservoirs by promotion of apoptosis and inhibition of autophagy: Targeting intracellular molecules in cure‐directed strategies

A. Rice, M. Mohan, Min Li, 2022, Journal of leukocyte biology.

Glycosyl Phosphatidylinositol-Anchored C34 Peptide Derived From Human Immunodeficiency Virus Type 1 Gp41 Is a Potent Entry Inhibitor

P. Zhou, Qianqian Zhu, J. Kimata, 2016, Journal of Neuroimmune Pharmacology.

A nonneutralizing anti-HIV Type 1 antibody turns into a broad neutralizing antibody when expressed on the surface of HIV type 1-susceptible cells. II. Inhibition of HIV type 1 captured and transferred by DC-SIGN.

R. Arora, P. Zhou, J. Allan, 2006, AIDS research and human retroviruses.

Domains of macaque DC-SIGN essential for capture and transfer of simian immunodeficiency virus.

J. Kimata, J. Biggins, Monica T Yu Kimata, 2004, Virology.

Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions.

G. Ayala, J. Kimata, Bryan Danielson, 2010, The Journal of infectious diseases.

HIV Detection in Wastewater as a Potential Epidemiological Bellwether

A. Maresso, T. Giordano, J. Kimata, 2022, SSRN Electronic Journal.

Author Correction: Clearance of HIV infection by selective elimination of host cells capable of producing HIV

E. Graviss, Min Chen, Jin Wang, 2020, Nature Communications.

Replication of Zika Virus in Human Prostate Cells: A Potential Source of Sexually Transmitted Virus

A. Lahon, R. Arya, D. Rowley, 2018, Journal of Infectious Diseases.

Long-acting refillable nanofluidic implant confers protection against SHIV infection in nonhuman primates

M. Ittmann, A. Grattoni, P. Anderson, 2023, Science Translational Medicine.

Engineered CD4 T cells expressing a membrane anchored viral inhibitor restrict HIV-1 through cis and trans mechanisms

J. Kimata, Lihong Liu, M. Wen, 2023, Frontiers in immunology.

Potent and Broad Anti-HIV-1 Activity Exhibited by a Glycosyl-Phosphatidylinositol-Anchored Peptide Derived from the CDR H3 of Broadly Neutralizing Antibody PG16

Y. Shao, P. Zhou, Mengran Qian, 2011, Journal of Virology.

Antiviral potency of long-acting islatravir subdermal implant in SHIV-infected macaques.

A. Grattoni, R. Arduino, Lane R. Bushman, 2023, Journal of controlled release : official journal of the Controlled Release Society.

A decrease in albumin in early SIV infection is related to viral pathogenicity.

J. Overbaugh, M. Wener, S. Holte, 2009, AIDS research and human retroviruses.